Objective:

To provide a comprehensive clinical review of ocular herpes simplex virus (HSV) and herpes zoster virus (VZV), focusing on diagnosis, management, and chronic disease prevention.

Approach:

Key Findings:

• HSV-1 is the most common ocular viral pathogen.
• HZO prevalence is increasing with an aging population.
• Both HSV and VZV can reactivate due to declining immunity.
• Differentiating between infectious and immune-mediated diseases is critical for treatment.
• Emerging evidence supports long-term suppressive therapy for HZO.

Interpretation:

The presentation emphasizes the importance of recognizing herpetic eye disease patterns to prevent misdiagnosis and complications.

Limitations:

• The study does not address the effectiveness of treatments in all patient populations.
• Long-term outcomes of new treatment strategies are not fully established.

Conclusion:

Early recognition and management of herpetic eye disease are crucial for preserving vision and reducing complications.

Sources:

• 2026 AOA Presentation
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.